Surrozen completes SPAC merger; Nasdaq listing under SRZN/SRZNW on Aug 12

Surrozen, Inc./DE

Business combination with Consonance-HFW Acquisition Corp. closed August 11, 2021.
Common stock and warrants start trading on Nasdaq August 12 under SRZN and SRZNW.
Transaction approved by Consonance-HFW shareholders on August 10 and Surrozen stockholders.
Existing management, led by CEO Craig Parker, to continue leading the combined company.
Surrozen focuses on Wnt pathway therapeutics for tissue repair and regeneration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.